47.84USD-2.70%Mkt Cap: —P/E: 36.411d ago
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree…
Industry Peers
Drug Manufacturers - General$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$190.75BUSDP/E 11.3
$183.02BUSD
$160.96BUSDP/E 37.2
$138.11BUSDP/E 14.9
$101.30BUSDP/E 24.0
$98.67BUSDP/E 16.3
$51.91BUSD
$32.74BUSDP/E 39.4
MRV
Marvell Technology, Inc.$26.57BUSDP/E 10.1
$12.10BUSDP/E 18.9
Key Statistics
Company
Market Cap—
Enterprise Value2.55B $
Revenue (TTM)830.44M $
Gross Profit605.31M $
Net Income (TTM)-109.89M $
Revenue/Share14.46 USD
Last Price47.84 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees778
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS8684591089
Valuation
P/E (Trailing)36.41
P/E (Forward)—
PEG—
EV/EBITDA23.08
EV/Revenue3.07
P/S—
P/B2.76
EPS (TTM)1.31
EPS (Forward)—
52W Range
47.0033% of range49.57
52W High49.57 USD
52W Low47.00 USD
Profitability
Gross Margin72.89%
Oper. Margin-2.48%
EBITDA Margin13.30%
Profit Margin-13.23%
ROE-10.49%
ROA0.39%
Growth
Revenue Growth32.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF19.91M $
CapEx (TTM)—
FCF Margin10.19%
FCF Yield—
Net Debt-331.90M $
Net Debt/EBITDA-3.01
Balance Sheet
Debt/Equity3.90
Current Ratio2.08
Quick Ratio1.68
Book Value/Sh17.73 USD
Cash/Share6.401 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.52.26M
Float51.67M
Insiders4.49%
Institutions106.74%
Technical
SMA 5027.93 (+71.3%)
SMA 20029.84 (+60.3%)
Beta0.56
S&P 52W Chg20.80%
Avg Vol (30d)7
Avg Vol (10d)90
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—